Provision and Delivery of Survivorship Care for Adult Patients with Haematological Malignancies: A Scoping Review Protocol

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2023 Mar 2

PMID 36862719

Authors

Zoe-Anne V Baldwin

Steph Busby

David Allsup

Judith Cohen

Olufikayo Bamidele

Affiliations

Soon will be listed here.

Abstract

Introduction: Haematological malignancies are a heterogenous group of blood and lymphatic cancers. Survivorship care is a similarly diverse term concerning patients' health and wellbeing from diagnosis to end of life. Survivorship care for patients with haematological malignancies has traditionally been consultant-led and secondary care-based, although shifts away from this model have been occurring, largely via nurse-led clinics and interventions with some remote monitoring. However, there remains a lack of evidence regarding which model is most appropriate. Although previous reviews exist, patient populations, methodologies, and conclusions are varied, and further high-quality research and evaluation has been recommended.

Aims: The aim of the scoping review this protocol describes is to summarise current evidence on the provision and delivery of survivorship care for adult patients diagnosed with a haematological malignancy, and to identify existing gaps to inform future research.

Methodology: A scoping review will be carried out utilising Arksey and O'Malley's guidelines as its methodological framework. Studies published in the English language from December 2007 to the present will be searched on bibliographic databases, including Medline, CINAHL, PsycInfo, Web of Science, and Scopus. Papers' titles, abstracts, and full text will predominantly be screened by one reviewer with a second reviewer blind screening a proportion. Data will be extracted using a customised table developed in collaboration with the review team, and presented in tabular and narrative format, arranged thematically. Studies included will contain data regarding adult (25+) patients diagnosed with any haematological malignancy in combination with aspects related to survivorship care. The survivorship care elements could be delivered by any provider within any setting, but should be delivered pre- or post-treatment, or to patients on a watchful waiting pathway.

Registration: The scoping review protocol has been registered on the Open Science Framework (OSF) repository Registries (https://osf.io/rtfvq; DOI: 10.17605/OSF.IO/RTFVQ).

References

Taylor K, Chan R, Monterosso L . Models of survivorship care provision in adult patients with haematological cancer: an integrative literature review. Support Care Cancer. 2015; 23(5):1447-58. DOI: 10.1007/s00520-015-2652-6. View

Mohanraj L, Sargent L, Brown R, Swift-Scanlan T . Frailty in Patients With Hematologic Malignancies and Those Undergoing Transplantation: A Scoping Review. Oncol Nurs Forum. 2021; 48(3):291-307. DOI: 10.1188/21.ONF.291-307. View

Taylor K, Monterosso L . Survivorship Care Plans and Treatment Summaries in Adult Patients With Hematologic Cancer: An Integrative Literature Review. Oncol Nurs Forum. 2015; 42(3):283-91. DOI: 10.1188/15.ONF.283-291. View

Hamaker M, Prins M, Stauder R . The relevance of a geriatric assessment for elderly patients with a haematological malignancy--a systematic review. Leuk Res. 2014; 38(3):275-83. DOI: 10.1016/j.leukres.2013.12.018. View

Di Molfetta S, Daniele A, Gerardi C, Allocati E, Minoia C, Loseto G . Late Endocrine and Metabolic Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi. Cancers (Basel). 2022; 14(6). PMC: 8946842. DOI: 10.3390/cancers14061439. View

Tricco A, Lillie E, Zarin W, OBrien K, Colquhoun H, Levac D . PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018; 169(7):467-473. DOI: 10.7326/M18-0850. View

Allart P, Soubeyran P, Cousson-Gelie F . Are psychosocial factors associated with quality of life in patients with haematological cancer? A critical review of the literature. Psychooncology. 2012; 22(2):241-9. DOI: 10.1002/pon.3026. View

Horsboel T, de Thurah A, Nielsen B, Nielsen C . Factors associated with work outcome for survivors from haematological malignancies--a systematic literature review. Eur J Cancer Care (Engl). 2012; 21(4):424-35. DOI: 10.1111/j.1365-2354.2012.01348.x. View

Minoia C, Gerardi C, Allocati E, Daniele A, De Sanctis V, Bari A . The Impact of Healthy Lifestyles on Late Sequelae in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors. A Systematic Review by the Fondazione Italiana Linfomi. Cancers (Basel). 2021; 13(13). PMC: 8268176. DOI: 10.3390/cancers13133135. View

10.

Tsatsou I, Konstantinidis T, Kalemikerakis I, Adamakidou T, Vlachou E, Govina O . Unmet Supportive Care Needs of Patients with Hematological Malignancies: A Systematic Review. Asia Pac J Oncol Nurs. 2021; 8(1):5-17. PMC: 7785074. DOI: 10.4103/apjon.apjon_41_20. View

11.

Langer S, Lehane C, Yi J . Patient and Caregiver Adjustment to Hematopoietic Stem Cell Transplantation: a Systematic Review of Dyad-Based Studies. Curr Hematol Malig Rep. 2017; 12(4):324-334. DOI: 10.1007/s11899-017-0391-0. View

12.

Signorelli C, Wakefield C, Fardell J, Wallace W, Robertson E, McLoone J . The impact of long-term follow-up care for childhood cancer survivors: A systematic review. Crit Rev Oncol Hematol. 2017; 114:131-138. DOI: 10.1016/j.critrevonc.2017.04.007. View

13.

Oliva S, Puzzovivo A, Gerardi C, Allocati E, De Sanctis V, Minoia C . Late Cardiological Sequelae and Long-Term Monitoring in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi. Cancers (Basel). 2022; 14(1). PMC: 8750391. DOI: 10.3390/cancers14010061. View

14.

Viviani S, Caccavari V, Gerardi C, Ramadan S, Allocati E, Minoia C . Male and Female Fertility: Prevention and Monitoring Hodgkin' Lymphoma and Diffuse Large B-Cell Lymphoma Adult Survivors. A Systematic Review by the Fondazione Italiana Linfomi. Cancers (Basel). 2021; 13(12). PMC: 8228520. DOI: 10.3390/cancers13122881. View

15.

Franceschetti S, Annunziata M, Agostinelli G, Gerardi C, Allocati E, Minoia C . Late Neurological and Cognitive Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi. Cancers (Basel). 2021; 13(14). PMC: 8307605. DOI: 10.3390/cancers13143401. View

16.

Atakul E, Akyar I . Frailty Prevalence and Characteristics in Older Adults with Hematologic Cancer: a Descriptive Study. Asia Pac J Oncol Nurs. 2019; 6(1):43-49. PMC: 6287383. DOI: 10.4103/apjon.apjon_35_18. View

17.

Smith A, Howell D, Crouch S, Painter D, Blase J, Wang H . Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort. Int J Epidemiol. 2018; 47(3):700-700g. PMC: 6005016. DOI: 10.1093/ije/dyy044. View

18.

Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015; 350:g7647. DOI: 10.1136/bmj.g7647. View

19.

Damlaj M, El Fakih R, Hashmi S . Evolution of survivorship in lymphoma, myeloma and leukemia: Metamorphosis of the field into long term follow-up care. Blood Rev. 2018; 33:63-73. DOI: 10.1016/j.blre.2018.07.003. View

20.

Bugos K . Issues in adult blood cancer survivorship care. Semin Oncol Nurs. 2015; 31(1):60-6. DOI: 10.1016/j.soncn.2014.11.007. View